Landmark TrialRCTRandomized Controlled Trial
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
New England Journal of Medicine2010IF: 25.4
The ACCORD Study Group
Abstract
In patients with type 2 diabetes at high risk for cardiovascular events, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, did not reduce the rate of a composite outcome of fatal and nonfatal major cardiovascular events. (ClinicalTrials.gov number, NCT00000620.)